Cargando…

Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

INTRODUCTION: Hypercholesterolemia is a well-known risk factor for developing atherosclerosis and subsequently for the risk of a myocardial infarction (MI). Moreover, it might also be related to the extent of damaged myocardium in the event of a MI. The aim of this study was to evaluate the associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bodde, Mathijs C., Hermans, Maaike P. J., Wolterbeek, Ron, Cobbaert, Christa M., van der Laarse, Arnoud, Schalij, Martin J., Jukema, J. Wouter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525214/ https://www.ncbi.nlm.nih.gov/pubmed/30758783 http://dx.doi.org/10.1007/s40119-019-0126-5

Ejemplares similares

Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention
por: Bodde, Mathijs C., et al.
Publicado: (2019)

Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up
por: Bodde, Mathijs C., et al.
Publicado: (2018)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Asymmetric Dimethylarginine (ADMA) Levels Display a Morning Peak in Patients with Acute Myocardial Infarction
por: Bergheanu, Sandrin C., et al.
Publicado: (2011)

Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease
por: Buiten, Maurits S., et al.
Publicado: (2015)

Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
por: Renee Ruhaak, L, et al.
Publicado: (2019)

Original Research: Long-Term Prognosis After ST-Elevation Myocardial Infarction in Patients with a Prior Cancer Diagnosis
por: Heemelaar, Julius C., et al.
Publicado: (2021)

Myocardial infarction patients referred to the primary care physician after 1‑year treatment according to a guideline-based protocol have a good prognosis
por: Bodde, M. C., et al.
Publicado: (2019)

Frailty score for elderly patients is associated with short-term clinical outcomes in patients with ST-segment elevated myocardial infarction treated with primary percutaneous coronary intervention
por: Hermans, M. P. J., et al.
Publicado: (2019)

Intensity of Statin Treatment in Korean Patients with Acute Myocardial Infarction and Very Low LDL Cholesterol
por: Sim, Doo Sun, et al.
Publicado: (2019)

High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine
por: Reijnders, E., et al.
Publicado: (2023)

Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination
por: Trion, Astrid, et al.
Publicado: (2007)

Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)
por: Makhmudova, Umidakhon, et al.
Publicado: (2023)

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
por: Schwartz, Gregory G., et al.
Publicado: (2021)

The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
por: Parish, Sarah, et al.
Publicado: (2009)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

Admission homocysteine is an independent predictor of spontaneous reperfusion and early infarct-related artery patency before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction
por: Li, Jing, et al.
Publicado: (2018)

Non-ST-elevation myocardial infarction in the Netherlands: room for improvement!
por: Ten Have, P., et al.
Publicado: (2020)

Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study
por: Wongcharoen, Wanwarang, et al.
Publicado: (2017)

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk
por: Orsi, Fernanda A, et al.
Publicado: (2019)

Targeting LDL Cholesterol With LNA
por: Krieg, Arthur M
Publicado: (2012)

Cellular itinerary of LDL cholesterol
por: Vance, Jean E.
Publicado: (2022)

COVID-19 pandemic and the reduction in ST-elevation myocardial infarction admissions
por: Kulkarni, Prashanth, et al.
Publicado: (2020)

LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Admission hyperglycemia predicts poorer short‐ and long‐term outcomes after primary percutaneous coronary intervention for ST‐elevation myocardial infarction
por: Chen, Pei‐Chi, et al.
Publicado: (2014)

Impact of admission blood glucose levels on prognosis of elderly patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention
por: Ekmekci, Ahmet, et al.
Publicado: (2013)

Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention
por: Hao, Yuanyuan, et al.
Publicado: (2017)

The Association Between Admission Heart Failure and In-Hospital Outcomes in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
por: Elkammash, Amr, et al.
Publicado: (2022)

Association of admission testosterone level with ST-segment resolution in male patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Separham, Ahmad, et al.
Publicado: (2017)

Friedewald’s equation for calculating LDL-cholesterol: Is it the time to say “Goodbye” and adopt direct LDL cholesterol methods?
por: Khan, Sikandar Hayat, et al.
Publicado: (2019)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022)

Direct admission versus interhospital transfer for revascularisation in non‐ST‐segment elevation myocardial infarction
por: van Steenbergen, Gijs J., et al.
Publicado: (2023)

Admission glucose level and short-term mortality in older patients with acute myocardial infarction: results from the KORA Myocardial Infarction Registry
por: Mamadjanov, Temur, et al.
Publicado: (2021)

Temporal Trends of System of Care for STEMI: Insights from the Jakarta Cardiovascular Care Unit Network System
por: Dharma, Surya, et al.
Publicado: (2014)

Seasonal Variations in Hospital Admissions for ST-Elevation Myocardial Infarction in New Zealand
por: Swampillai, Janice, et al.
Publicado: (2012)

Association between admission anemia and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry
por: Colombo, Miriam Giovanna, et al.
Publicado: (2018)

Admission serum potassium concentration and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry
por: Colombo, Miriam Giovanna, et al.
Publicado: (2017)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c058kdghv6od4tscp8e05trcun